Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2013

Conditions
Sickle Cell Disease
Interventions
BIOLOGICAL

Enriched Hematopoetic Stem Cell Infusion

Enriched Hematopoetic Stem Cell Infusion

Trial Locations (3)

19134

St. Christopher's Hospital for Children, Pittsburgh

27705

Duke University Medical Center, Durham

40202

University of Louisville, Louisville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

St. Christopher's Hospital for Children

OTHER

collaborator

The Western Pennsylvania Hospital

OTHER

collaborator

University of Florida

OTHER

collaborator

Medical College of Pennsylvania Hospital

OTHER

collaborator

Hahnemann University Hospital

OTHER

lead

Talaris Therapeutics Inc.

INDUSTRY